Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Dec 03
 -0.64 / -0.31%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 265.00, with a high estimate of 341.00 and a low estimate of 175.00. The median estimate represents a +30.02% increase from the last price of 203.81.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.66%
Growthannually 25.13%


Growthquarterly 0.99%
Growthannually 20.96%
Key to the earnings and sales forecast charts.